Markers of severity in acute pancreatitis;Marcadores de gravedad en la pancreatitis aguda

Medicina Clinica

Volumn 128, Issue 11, 2007, Pages 417-418

  Folch Puy, Emma ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; PANCREAS ENZYME; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HUMAN; PATHOPHYSIOLOGY;

EID: 34247478141     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13100341     Document Type: Editorial

References (16)

1. Werner J, Feuerbach S, Uhl W, Buchler MW. Management of acute pancreatitis: from surgery to interventional intensive care. Gut. 2005;54:426-36.
2. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5:132-44.
3. Garcea G, Jackson B, Pattenden CJ, Sutton CD, Neal CP, Dennison AR, et al. Early warning scores predict outcome in acute pancreatitis. J Gastrointest Surg. 2006;10:1008-15.
4. Ayuso Colella C. Técnicas de imagen. Tomografía computarizada. En: Navarro S, Pérez-Mateo M, Guarner L, editores. Tratado de páncreas exocrino. Barcelona: J&C Ediciones Médicas; 2002. p. 69-76.
5. Rettally CA, Skarda S, Garza MA, Schenker S. The usefulness of laboratory tests in the early assessment of severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2003;40:117-49.
6. Johnson CD, Lempinen M, Imrie CW, Puolakkainen P, Kemppainen E, Carter R, et al. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg. 2004;91:1027-33.
7. Domínguez-Munoz JE, Villanueva A, Larino J, Mora T, Barreiro M, Iglesias-Canle J, et al. Accuracy of plasma levels of polymorphonuclear elastase as early prognostic marker of acute pancreatitis in routine clinical conditions. Eur J Gastroenterol Hepatol. 2006;18:79-83.
8. Yamauchl J, Shibuya K, Sunamura M, Arai K, Shimamura H, Motoi F, et al. Cytokine modulation in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2001;8:195-203.
9. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996;83:349-53.
10. Papachristou GI, Whitcomb DC. Inflammatory markers of disease severity in acute pancreatitis. Clin Lab Med. 2005;25:17-37.
11. Wereszczynska-Siemiatkowska U, Mroczko B, Siemiatkowski A, Szmitkowski M, Borawska M, Kosel J. The importance of interleukin 18, glutathione peroxidase, and selenium concentration changes in acute pancreatitis. Dig Dis Sci. 2004;49:642-50.
12. Nakae H, Endo S, Sato N, Wakabayashi G, Inada K, Sato S. Involvement of soluble adhesion molecules in acute pancreatitis. Eur Surg Res. 2001;33:377-82.
13. Shields CJ, Winter DC, Redmond HP. Lung injury in acute pancreatitis: mechanisms, prevention, and therapy. Curr Opin Crit Care. 2002;8:158-63.
14. Herrera Gutiérrez ME, Seller Pérez G, De la Rubia de Gracia C, Chaparro Sánchez MJ, Nacle López B. Características y valor pronóstico del fracaso renal agudo en la pancreatitis aguda grave. Med Clin (Barc). 2000;115:721-5.
15. Wang X, Zhao X, Shi C, Borjesson A, Chen Z, Axelsson J, et al. Potential mechanisms and significance of acute pancreatitis-associated liver injury. Scand J Gastroenterol. 2006;41:604-13.
16. Martín Alonso MA, Santamaría A, Saracíbar E, Arranz E, Garrote JA, Almaraz A, et al. Citocinas y otros parámetros inmunológicos como marcadores de alteración en órganos a distancia en la pancreatitis aguda. Med Clin (Barc). 2007;128:401-6.